How much does Bloodwise Trading Limited make?

Bloodwise Trading Limited reported revenue of £598k and £464k profit in the year to 31 Mar 2026, according to its accounts filed at Companies House.

Is Bloodwise Trading Limited profitable?

Yes — Bloodwise Trading Limited reported a profit of £464k in the year to 31 Mar 2026.

Company No. 01316717 · Incorporated 10 Jun 1977

Bloodwise Trading Limited

Registered name: BLOODWISE TRADING LIMITED

Part of Blood Cancer UK Research group

Bloodwise Trading Limited made £598k revenue and £464k profit in the year to 31 Mar 2026.

Bloodwise Trading Limited’s revenue grew 16% to £598k in the year to 31 Mar 2026, with £464k profit. The company is classified under “retail sale via mail order houses or via internet” and is based in London; we hold 3 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 47910Retail sale via mail order houses or via Internet

Status: Active
Location: London, London
Age: 49 yrs · since 1977
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Mar 2026

Key figures

Operating leverage

Revenue

£598k

Growth ▲16%

Profit

£464k

Growth ▲27.3%

Profit margin

77.5%

Gross 87%

Employees

—

Change —

Profit / employee

—

Profitable streak

3yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Mar 2024	31 Mar 2025	31 Mar 2026
Disclosure	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£662k	£516k	£598k
Cost of sales	−£80.4k	−£92.9k	−£78.1k
Gross profit	£582k	£423k	£520k
Operating profit	£523k	£350k	£453k
Profit before tax	£538k	£364k	£464k
Profit after tax	£538k	£364k	£464k
Profit (best available)	£538k	£364k	£464k
Employees (average)	—	—	—
Ratios
Profit margin	81.2%	70.7%	77.5%
Gross margin	87.9%	82%	87%
Growth (year on year)
Revenue growth	—	▼22.1%	▲16%
Profit growth	—	▼32.3%	▲27.3%
Balance sheet — indirect signals, not revenue
Net assets	—	—	—
Source	Accounts · bulk data Nov 2025	Accounts · bulk data Nov 2025	Accounts · bulk data Sep 2026

Derived from the latest filing

How the business works

Profit margin: 77.5%; Profit ÷ revenue.
Gross margin: 87%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: —; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now —
Cash at bank: —; Now —
Headcount: —; Now —
Deferred income: —; Now —
Fixed assets: —; Now —

Corporate ownership

Group structure

Ownership chain

Blood Cancer UK Researchultimate parent75–100%
Bloodwise Trading Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (2)

Bloodwise LtdFigures not disclosed
Leukaemia & Lymphoma Research LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from accounts for the year to 31 Mar 2026 (profit £464k), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.

Updated from Companies House on 13 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.